Loading...
 
Toggle Health Problems and D

Heart Failure Quality of Life greatly improved by 10,000 IU of vitamin D – RCT Oct 2017

Vitamin D3 repletion versus placebo as adjunctive treatment of heart failure patient quality of life and hormonal indices: a randomized, double-blind, placebo-controlled trial.

BMC Cardiovasc Disord. 2017 Oct 30;17(1):274. doi: 10.1186/s12872-017-0707-y.
Moretti HD1, Colucci VJ2,3, Berry BD4,2.
1 Providence Saint Patrick Hospital, 500 W. Broadway St, Missoula, MT, 59802, USA. heidi.moretti at providence.org.
2 International Heart Institute of Montana, 500 W. Broadway, Missoula, MT, 59802, USA.
3 University of Montana, 32 Campus Drive, Missoula, MT, 59812, USA.
4 Providence Saint Patrick Hospital, 500 W. Broadway St, Missoula, MT, 59802, USA.

VitaminDWiki

10,000 IU of Vitamin D daily for 6 months raised levels by 49 ng

Cardiovascular category starts with the following

507 items In Cardiovascular category

Cardiovascular category is associated with other categories: Diabetes 31, Omega-3 31 , Vitamin K 25 , Intervention 22 . Mortality 20 , Skin - Dark 18 , Magnesium 17 , Calcium 14 , Hypertension 14 , Trauma and surgery 13 , Stroke 13 , Kidney 12 , Metabolic Syndrome 11 , Seniors 10 , Pregnancy 8 as of Aug 2022


Cholesterol, Statins


 Download the PDF from VitaminDWiki

Image
Note: Kansas City Cardiomyopathy Questionnaire ranges from 0 (worst, with poor chance of survival) to 100

BACKGROUND:
Vitamin D status may influence heart failure (HF) patient outcomes by affecting b-type natriuretic peptide (BNP), parathyroid hormone (PTH), and enhancing cardiac contractility. Vitamin D deficiency is associated with morbidity and mortality in HF patients. The objective of this study was to determine if vitamin D3 at a comparatively high dose would replete 25-hydroxyvitamin D (25(OH)D) stores, improve BNP, PTH, cardiopulmonary function, reduce inflammatory markers, and improve quality of life (QOL) in HF patients.

METHODS:
This was a 6 month, parallel group, double-blind, placebo-controlled, single clinic center, randomized trial of supplemental vitamin D3 using a dose of 10,000 IU daily or placebo in 40 vitamin D deficient or insufficient (25(OH)D level ≤ 32 ng/ml) patients with stable New York Heart Association Class II-III HF in a specialty cardiology clinic. All variables were measured at baseline and 6 months. Values between the two treatment groups were assessed using Student's t-test or Mann-Whitney Test. Univariate analysis of covariance was conducted to adjust for variance in baseline 25(OH)D.

RESULTS:
All results were adjusted for baseline 25(OH)D. The change in BNP from baseline was ∆ +30 ± 950 pg/ml for treatment vs. placebo ∆ +400 ± 1900 pg/ml, p = 0.003. 25(OH)D serum levels rose by 49 ± 32 ng/ml in the treatment group vs 4 ± 10 ng/ml in the placebo group, p < 0.001. PTH and exercise chronotropic response index improved in the treatment group vs placebo group, respectively, but both were attenuated by adjustment ( (∆-20 ± 20 pg/ml vs ∆ + 7 ± 53 pg/ml respectively (p = 0.01, adjusted p = 0.07)) and (∆ + 0.13 ± 0.26 vs. ∆-0.03 ± 02.9 respectively, p < 0.01, adjusted p = 0.17)). Other measured cardiopulmonary parameters remained unchanged. High sensitivity C-reactive protein (hsCRP) remained unchanged for women, but improved for men (∆-2 ± 4 treatment versus ∆2 ± 5 mg/L placebo, p = 0.05).
QOL scores, including composite overall and clinical summary scores significantly improved in treatment compared to placebo (∆ + 10 ± 15 versus -6 ± 15, p < 0.01 and ∆ + 8 ± 14 versus -8 ± 18, p = 0.01, respectively).

CONCLUSIONS:
Repletion of 25(OH)D may improve QOL in HF patients and may help to normalize BNP, PTH, and hsCRP.

TRIAL REGISTRATION: Clinicaltrials.gov, NCT01636570 , First registered 3 July 2012.

PMID: 29084522 DOI: 10.1186/s12872-017-0707-y

Review of Study by Vitamin D Council


Created by admin. Last Modification: Monday November 13, 2017 17:03:55 GMT-0000 by admin. (Version 8)

Attached files

ID Name Comment Uploaded Size Downloads
8620 QoL Heart Failure 10,000 IU.jpg admin 01 Nov, 2017 19.75 Kb 617
8619 Heart failure QoL 10,000 IU.pdf admin 01 Nov, 2017 730.52 Kb 651